Sandbox Cardiovascular Drugs2/Cardiac Stimulants: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 13: Line 13:
! style="font-size: 80%; padding: 0 5px; background: #4479BA; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5)" align=left |[[Sandbox Cardiovascular Drugs2/Calcium Channel Blockers|{{Fontcolor|#F8F8FF|Calcium Channel Blockers}}]]
! style="font-size: 80%; padding: 0 5px; background: #4479BA; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5)" align=left |[[Sandbox Cardiovascular Drugs2/Calcium Channel Blockers|{{Fontcolor|#F8F8FF|Calcium Channel Blockers}}]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #4479BA; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5); box-shadow: inset 0 0 10px #F0F8FF;" align=left |[[Sandbox Cardiovascular Drugs2/Cardiac Stimulants|{{Fontcolor|#F8F8FF|Cardiac Stimulants}}]]
! style="font-size: 80%; padding: 0 5px; background: #4479BA; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: inset 0 0 10px #F0F8FF;" align=left |[[Sandbox Cardiovascular Drugs2/Cardiac Stimulants|{{Fontcolor|#F8F8FF|Cardiac Stimulants}}]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #4479BA; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5)" align=left |[[Sandbox Cardiovascular Drugs2/Diuretics|{{Fontcolor|#F8F8FF|Diuretics}}]]
! style="font-size: 80%; padding: 0 5px; background: #4479BA; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5)" align=left |[[Sandbox Cardiovascular Drugs2/Diuretics|{{Fontcolor|#F8F8FF|Diuretics}}]]

Revision as of 01:05, 30 July 2014